Stat5 opposes the transcription factor Tox and rewires exhausted CD8+ T cells toward durable effector-like states during chronic antigen exposure-Reference-Cited by-同舟云学术

Stat5 opposes the transcription factor Tox and rewires exhausted CD8+ T cells toward durable effector-like states during chronic antigen exposure

Published:2023-12 Issue:12 Volume:56 Page:2699-2718.e11
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Beltra Jean-Christophe,Abdel-Hakeem Mohamed S.,Manne Sasikanth,Zhang Zhen,Huang Hua,Kurachi Makoto,Su Leon,Picton Lora,Ngiow Shin Foong,Muroyama Yuki,Casella Valentina,Huang Yinghui J.,Giles Josephine R.,Mathew Divij,Belman Jonathan,Klapholz Max,Decaluwe Hélène,Huang Alexander C.,Berger Shelley L.,Garcia K. Christopher,Wherry E. John

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference103 articles.

1. Prospects and challenges for use of CAR T cell therapies in solid tumors;Ramakrishna;Expert Opin. Biol. Ther.,2020

2. CD8 T cell exhaustion during chronic viral infection and cancer;McLane;Annu. Rev. Immunol.,2019

3. Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity;Collier;Nat. Immunol.,2021

4. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment;Wherry;J. Virol.,2003

5. Viral immune evasion due to persistence of activated T cells without effector function;Zajac;J. Exp. Med.,1998

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astragalus polysaccharide enhances antitumoral effects of chimeric antigen receptor- engineered (CAR) T cells by increasing CD122+CXCR3+PD-1- memory T cells;Biomedicine & Pharmacotherapy;2024-10

2. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09

3. Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends;Experimental & Molecular Medicine;2024-09-02

4. Reversal of T-cell exhaustion: Mechanisms and synergistic approaches;International Immunopharmacology;2024-09

5. Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma;Immunity;2024-09